12:00 AM
 | 
Aug 02, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Anti-ovarian cancer mAbs diagnostic data

In a retrospective analysis of 54 blood samples from 17 ovarian cancer patients, 5 patients with benign tumors of the ovaries and 32 healthy controls showed that MabCure's ovarian...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >